375 related articles for article (PubMed ID: 20600356)
1. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma.
Guérin M; Guillemot J; Thouënnon E; Pierre A; El-Yamani FZ; Montero-Hadjadje M; Dubessy C; Magoul R; Lihrmann I; Anouar Y; Yon L
Regul Pept; 2010 Nov; 165(1):21-9. PubMed ID: 20600356
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytoma: presentation, diagnosis and treatment.
Reisch N; Peczkowska M; Januszewicz A; Neumann HP
J Hypertens; 2006 Dec; 24(12):2331-9. PubMed ID: 17082709
[TBL] [Abstract][Full Text] [Related]
3. Development of novel tools for the diagnosis and prognosis of pheochromocytoma using peptide marker immunoassay and gene expression profiling approaches.
Anouar Y; Yon L; Guillemot J; Thouennon E; Barbier L; Gimenez-Roqueplo AP; Bertherat J; Lefebvre H; Klein M; Muresan M; Grouzmann E; Plouin PF; Vaudry H; Elkahloun AG
Ann N Y Acad Sci; 2006 Aug; 1073():533-40. PubMed ID: 17102122
[TBL] [Abstract][Full Text] [Related]
4. Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.
Guillemot J; Thouënnon E; Guérin M; Vallet-Erdtmann V; Ravni A; Montéro-Hadjadje M; Lefebvre H; Klein M; Muresan M; Seidah NG; Anouar Y; Yon L
J Mol Endocrinol; 2012 Apr; 48(2):115-27. PubMed ID: 22217803
[TBL] [Abstract][Full Text] [Related]
5. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of Secretogranins II and III in Canine Adrenal Chromaffin Cells and Pheochromocytomas.
Gomi H; Nagumo T; Asano K; Konosu M; Yasui T; Torii S; Hosaka M
J Histochem Cytochem; 2022 May; 70(5):335-356. PubMed ID: 35400231
[TBL] [Abstract][Full Text] [Related]
7. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
Portela-Gomes GM; Stridsberg M; Grimelius L; Falkmer UG; Falkmer S
APMIS; 2004 Oct; 112(10):663-73. PubMed ID: 15601318
[TBL] [Abstract][Full Text] [Related]
8. Expression and processing of the neuroendocrine protein secretogranin II in benign and malignant pheochromocytomas.
Guillemot J; Barbier L; Thouennon E; Vallet-Erdtmann V; Montero-Hadjadje M; Lefebvre H; Klein M; Muresan M; Plouin PF; Seidah N; Vaudry H; Anouar Y; Yon L
Ann N Y Acad Sci; 2006 Aug; 1073():527-32. PubMed ID: 17102121
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic management of benign and malignant pheochromocytoma.
Scholz T; Schulz C; Klose S; Lehnert H
Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):155-9. PubMed ID: 17427102
[TBL] [Abstract][Full Text] [Related]
10. Pheochromocytomas and secreting paragangliomas.
Plouin PF; Gimenez-Roqueplo AP
Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
[TBL] [Abstract][Full Text] [Related]
11. [Causes of recurrence of patients with chromaffin tumors].
Bel'tsevich DG; Kuznetsov NS
Khirurgiia (Mosk); 2002; (8):19-23. PubMed ID: 12389495
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of tumors of the adrenal medulla.
Ilias I; Pacak K
Horm Metab Res; 2005 Dec; 37(12):717-21. PubMed ID: 16372223
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in diagnosis and treatment of pheochromocytoma.
Veglio F; Morello F; Morra Di Cella S; Del Colle S; Rabbia F; Mulatero P
Minerva Med; 2003 Aug; 94(4):267-71. PubMed ID: 14605591
[TBL] [Abstract][Full Text] [Related]
15. [Personal experience in diagnosis and localization of pheochromocytoma].
Andjelković Z; Tavcar I
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992
[TBL] [Abstract][Full Text] [Related]
16. Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma.
Guillemot J; Anouar Y; Montero-Hadjadje M; Grouzmann E; Grumolato L; Roshmaninho-Salgado J; Turquier V; Duparc C; Lefebvre H; Plouin PF; Klein M; Muresan M; Chow BK; Vaudry H; Yon L
Int J Cancer; 2006 Apr; 118(8):2003-12. PubMed ID: 16287097
[TBL] [Abstract][Full Text] [Related]
17. [Pheochromocytoma in Dakar: report of nine cases].
Leye A; Pouye A; Fall B; Sidibe EH; Dangou JM; Kane A; Mbaye PS; Ka MM; Moreira-Diop T
Dakar Med; 2003; 48(2):77-81. PubMed ID: 15770796
[TBL] [Abstract][Full Text] [Related]
18. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.
Tischler AS; Freund R; Carroll J; Cahill AL; Perlman RL; Alroy J; Riseberg JC
Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784
[TBL] [Abstract][Full Text] [Related]
19. Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors.
Yon L; Guillemot J; Montero-Hadjadje M; Grumolato L; Leprince J; Lefebvre H; Contesse V; Plouin PF; Vaudry H; Anouar Y
J Clin Endocrinol Metab; 2003 Jun; 88(6):2579-85. PubMed ID: 12788858
[TBL] [Abstract][Full Text] [Related]
20. Granins and catecholamines: functional interaction in chromaffin cells and adipose tissue.
Borges R; Dominguez N; Smith CB; Bandyopadhyay GK; O'Connor DT; Mahata SK; Bartolomucci A
Adv Pharmacol; 2013; 68():93-113. PubMed ID: 24054141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]